Product
Patsnap Eureka
For R&D, Patsnap Eureka makes reading and utilizing patents & technical documents easy.
Patsnap Eureka AIR
Designed for self-driven R&D workflows. Generate viable solutions, solve complex R&D challenges, empower your innovation with AI.
Patsnap Eureka Materials
Designed for material experts only. Revolutionize your material R&D, from search, analyze, to developing new materials.
Feature
TechResearch
Generate reliable direction feasibility study reports for your R&D in just a few steps.
TechSeek
Discover and master advanced knowledge NOW. Basics, ideas, possibilities, all at once.
TechMind
As an expert in R&D Theories, TechMind can generates customized viable solutions instantly.
TechRisk
Analyze your overall solution with one click, know your potential R&D risks in advance.
TechMonitor
Get weekly tech updates, stay abreast of the latest tech innovations and key insights.
Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
343results about "Lactose production" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Algae biomass fractionation
A method of fractionating biomass, by permeability conditioning biomass suspended in a pH adjusted solution of at least one water-based polar solvent to form a conditioned biomass, intimately contacting the pH adjusted solution with at least one non-polar solvent, partitioning to obtain an non-polar solvent solution and a polar biomass solution, and recovering cell and cell derived products from the non-polar solvent solution and polar biomass solution. Products recovered from the above method. A method of operating a renewable and sustainable plant for growing and processing algae.
Owner:VALICOR
Continuous process for the production of anhydrosugar alcohols
A process is described for continuous production of anhydrosugar alcohol by continuous introducing of sugar alcohols and / or monoanhydrosugar alcohols into a reaction vessel and dehydration in the presence of an acid catalyst and solvent in which the resultant reaction product is soluble. Water and the solvent having the dissolved reaction product are each cointinuously removed from the reaction vessel. The reaction product is separated from the removed solvent and the product is optionally purified to a purity of 99.0% the solvent is recycled in the reaction vessel.
Owner:EI DU PONT DE NEMOURS & CO
Particles, especially microparticles or nanoparticles, of crosslinked monosaccharides and oligosaccharides, processes for their preparation and cosmetic, pharmaceutical or food compositions in which they are present
InactiveUS6197757B1Demonstrates their biodegradabilityAccurate timingBiocideCosmetic preparationsEmulsionNanoparticle
Particles comprising an outer wall formed of one or more saccharide components selected from the group consisting of monosaccharides and oligosaccharides crosslinked by interfacial crosslinking in emulsion, preferably at room temperature, with a polyfunctional acylating crosslinking agent to produce ester linkages between the acylatable hydroxyl group(s) of the primary alcohol(s) of the saccharide component and the acyl groups of the polyfunctional acylating agent. These particles can be used for the manufacture of cosmetic, pharmaceutical and food compositions.
Owner:BASF BEAUTY CARE SOLUTIONS FRANCE SAS
High titer production of highly linear poly (alpha 1,3 glucan)
ActiveUS8642757B2Improve mechanical propertiesMore amenable to preparing fibersSugar derivativesPeptide/protein ingredientsSucroseSaccharophagus degradans
Owner:NUTRITION & BIOSCIENCES USA 4 INC
Pharmaceutical materials and methods for their preparation and use
InactiveUS7001892B1Improve stabilityImproved shelf-lifePowder deliveryBiocideAdjuvantAdditive ingredient
Pharmaceutical compositions comprising crystals of a pharmaceutically-acceptable crystal lattice component, and an active pharmaceutical ingredient different from and included within the crystal lattice component in a growth-sector specific orientation. The crystals are prepared using components and methods which yield crystals having suitable purity and efficacy for use in administering the active pharmaceutical ingredients to a patient. The crystals are typically combined with adjuvants such as excipients, diluents or carriers, and are preferably formulated into tablets, capsules, suspensions, and other conventional forms containing predetermined amounts of the pharmaceuticals. Also provided are methods for preparing the crystals, and methods for storing and administering the active pharmaceutical ingredient either included within the crystals or upon reconstitution of the crystals to a solution.
Owner:PURDUE RES FOUND INC
Chlorination of Sucrose-6-esters
InactiveUS20060205936A1Good yieldEasy to handleDisaccharidesFood preparationHydroxy compoundGalactosucrose
An improved process for chlorination of sugars produces chlorodeoxy derivatives, in particular the chlorination of sucrose-6-esters to produce sucralose (4,1′,6′-trichloro-4,1′,6′-trideoxy galactosucrose), with thionyl chloride and N,N-dimethyl formamide (DMF) at the ration of about 1 molar equivalent of thionyl chloride for every molar equivalent of free hydroxyl group.
Owner:SL LAB
Galactoside inhibitors of galectins
InactiveUS7638623B2Process economyHigh affinityEsterified saccharide compoundsOrganic active ingredientsDiseaseMedicine
Owner:GALECTO BIOTECH
Crystalline form of sucralose, and method for producing it
A crystalline form of sucralose, and a method of making it. The method involves continuously crystallizing sucralose from an aqueous solution by a process providing continuous removal and recirculation of the vessel contents, and providing a long residence time for sucralose in the system. The crystals thus formed are of a relatively low length / diameter ratio, have an unsymmetrical shape, and exhibit good stability. The larger crystals in particular are tapered as compared to the rod-like larger crystals in prior art product.
Owner:TATE & LYLE TECH LTD
Two-stage dehydration of sugars
InactiveUS20070173651A1Oxygen-containing compound preparationSugar derivativesContinuous reactorAlcohol
The invention includes methods for producing dianhydrosugar alcohol by providing an acid catalyst within a reactor and passing a starting material through the reactor at a first temperature. At least a portion of the staring material is converted to a monoanhydrosugar isomer during the passing through the column. The monoanhydrosugar is subjected to a second temperature which is greater than the first to produce a dianhydrosugar. The invention includes a method of producing isosorbide. An initial feed stream containing sorbitol is fed into a continuous reactor containing an acid catalyst at a temperature of less than 120° C. The residence time for the reactor is less than or equal to about 30 minutes. Sorbitol converted to 1,4-sorbitan in the continuous reactor is subsequently provided to a second reactor and is dehydrated at a temperature of at least 120° C. to produce isosorbide.
Owner:BATTELLE MEMORIAL INST
Method for normalizing insulin levels
The invention is directed to a dietary supplement which contains mannoheptulose. Mannoheptulose occurs naturally in avocado fruit. The dietary supplement and its method of use can lower serum insulin levels and lower a subject's weight. The dietary supplement in its disclosed form includes a controlled release system for mannoheptulose. The dietary supplement may also include one or more amino acids.
Owner:QUALITY VITAMINS
Process for producing sugar chain asparagine derivative
InactiveUS20040181054A1Conveniently obtainEsterified saccharide compoundsSugar derivativesSugarMedicinal chemistry
The present invention provides a process for preparing a sugar chain asparagine derivative. According to the process, various isolated sugar chain asparagine derivatives useful in the field of the development of pharmaceuticals and the like can be conveniently obtained in a large amount as compared to that of the prior art. The present invention also provides a process for preparing a sugar chain asparagine and a process for preparing a sugar chain via a step for preparing a sugar chain asparagine derivative. The present invention further provides a novel sugar chain asparagine derivative, a sugar chain asparagine and a sugar chain.
Owner:YASUHIRO KAJIHARA +1
Synthetic glucopyranosyl lipid adjuvants
Compounds, particularly, glucopyranosyl lipid adjuvant (GLA) compounds, having the following structure (I) are provided:or a pharmaceutically acceptable salt thereof, wherein L1, L2, L3, L4, L5, L6, L7, L8, L9, L10, Y1, Y2, Y3, Y4, R1, R2, R3, R4, R5, R6, are as defined herein. Pharmaceutical compositions, vaccine compositions, and related methods for inducing or enhancing immune responses, are also provided.
Owner:ACCESS TO ADVANCED HEALTH INST
Crystallization of sugars
InactiveUS6579375B2Reduce in quantityPromote growthDough treatmentMilk preservationCrystallinitySolvent
A process for preparing crystalline sugar by providing a solution of a solvent and sugar, exposing the solution to a magentic field having a strength which is sufficient to impart improvements in the processing of the sugar or the properties of the resulting crystalline sugar product, and providing conditions suitable for crystallization to obtain a substantially crystalline sugar product. The magnetic field strength is sufficient to influence at least one of morphology, size, nucleation rate or, crystallinity of the crystalline sugar product.
Owner:NESTEC SA
Heterobifunctional pan-selectin inhibitors
ActiveUS20070054870A1Avoid stickingAntibacterial agentsOrganic active ingredientsGlycomimeticSelectin
Compounds and methods are provided for modulating in vitro and in vivo processes mediated by selectin binding. More specifically, selectin modulators and their use are described, wherein the selectin modulators that modulate (e.g., inhibit or enhance) a selectin-mediated function comprise particular glycomimetics alone or linked to a member of a class of compounds termed BASAs (Benzyl Amino Sulfonic Acids) or a member of a class of compounds termed BACAs (Benzyl Amino Carboxylic Acids).
Owner:GLYCOMIMETICS
Dry mouldable drug formulation
InactiveUS20050202072A1Easy and rapid and essentially painless injectionHigh strengthOrganic active ingredientsPowder deliveryParenteral nutritionDrug formulations
Solid pharmaceutical compositions for parenteral injection comprising a binder and at least one therapeutic agent. The pharmaceutical composition has the strength to be injected directly with the need of using cannulas or the like.
Owner:NOVO NORDISK AS
Use of hyaluronidase in the manufacture of an ophthalmic preparation for liquefying vitreous humor in the treatment of eye disorders
InactiveUS6863886B2Improve clearance rateIncreases rate of liquid exchangeBiocidePeptide/protein ingredientsDiseaseHyaluronidase
An enzymatic method is provided for treating ophthalmic disorders of the mammalian eye. Prevention of neovascularization and the increased rate of clearance from the vitreous of materials toxic to retina is accomplished by administering an amount of hyaluronidase effective to liquefy the vitreous humor of the treated eye without causing toxic damage to the eye. Liquefaction of the vitreous humor increases the rate of liquid exchange from the vitreal chamber. This increase in exchange removes those materials and conditions whose presence causes ophthalmological and retinal damage.
Owner:BAUSCH & LOMB PHARMA HLDG
Aminosugar and glycosaminoglycan composition for the treatment and repair of connective tissue
Owner:NUTRAMAX LABORATORIES INC
Methods and compositions for administration of iron
The present invention generally relates to treatment of iron-related conditions with iron carbohydrate complexes. One aspect of the invention is a method of treatment of iron-related conditions with a single unit dosage of at least about 0.6 grams of elemental iron via an iron carbohydrate complex. The method generally employs iron carbohydrate complexes with nearly neutral pH, physiological osmolarity, and stable and non-immunogenic carbohydrate components so as to rapidly administer high single unit doses of iron intravenously to patients in need thereof.
Owner:AMERICAN REGENT INC
Reductive biomass liquefaction
ActiveUS20120172579A1Oxygen-containing compound preparationLiquid hydrocarbon mixture productionCyclic etherBiofuel
The present invention provides methods, reactor systems, and catalysts for converting in a continuous process biomass to less complex oxygenated compounds for use in downstream processes to produce biofuels and chemicals. The invention includes methods of converting the components of biomass, such as hemicellulose, cellulose and lignin, to water-soluble materials, including lignocellulosic derivatives, cellulosic derivatives, hemicellulosic derivatives, carbohydrates, starches, polysaccharides, disaccharides, monosaccharides, sugars, sugar alcohols, alditols, polyols, diols, alcohols, ketones, cyclic ethers, esters, carboxylic acids, aldehydes, and mixtures thereof, using hydrogen and a heterogeneous liquefaction catalyst.
Owner:VIRENT
Crystallization of sugars
InactiveUS20030084898A1Attractive bright and shiny appearanceProduced conveniently and consistentlyMilk preservationDough treatmentNucleationCrystallinity
A process for preparing crystalline sugar by providing a solution of a solvent and sugar, exposing the solution to a magentic field having a strength which is sufficient to impart improvements in the processing of the sugar or the properties of the resulting crystalline sugar product, and providing conditions suitable for crystallization to obtain a substantially crystalline sugar product. The magnetic field strength is sufficient to influence at least one of morphology, size, nucleation rate or, crystallinity of the crystalline sugar product.
Owner:NESTEC SA
Heparin oligosaccharides
ActiveUS20060079483A1Reduces or eliminates at least one symptom of the diseaseOrganic active ingredientsSugar derivativesHeparinoidsCombinatorial chemistry
The present invention provides composition and methods for the synthesis of low molecular weight heparins and heparinoids. The present invention also provides compositions having substantially homogenous populations of desired heparin molecules, or molecules useful in the synthesis of heparin oligosaccharides.
Owner:ACAD SINIC
High-intensity sweetener composition and delivery of same
A composition for sweetening ingestable solids or liquids. The composition is compressed and comprises less than about 7.5 weight-% sucralose and one or more diluents. The composition is compressed at a pressure of greater than 2 pounds per square inch. A method of forming the composition and a system for delivering the composition are also provided.
Owner:HEARTLAND CONSUMER PROD
Process and plant for evaporative concentration and crystallization of a viscous lactose-containing aqueous liquid
InactiveUS20030196957A1Crystallization separationSugar crystallisationLiquid crystallineParticulates
Crystalline alpha-lactose monohydrate is recovered frown a viscous lactose-containing aqueous liquid by subjecting said liquid to simultaneous heating, removal of evaporated vapor and mechanical agitation at high shear rate to provide a crystallization promoting decrease of the viscosity of the liquid with crystals formed and suspended therein to progressively concentrate the agitated liquid and simultaneously crystallize lactose therefrom. Subsequent cooling, drying, and disintegration yield particulate alpha-lactose monohydrate.
Owner:NIRO
Process for crystallizing amorphous lactose in milk powder
The present process is directed to a method of crystallizing the lactose in milkfat which comprises (a) mixing the milk powder with water in an amount sufficient to initiate crystallization when subjected to shearing and heating, and (b) subjecting the product of (a) to shearing and heating under conditions effective to crystallize the lactose, said heating being conducted at a temperature greater than the glass transition temperature of the lactose and below the temperature at which the product will have a burnt flavor.
Owner:THE HERSHEY COMPANY
Sugar mixtures and methods for production and use thereof
A sugar mixture comprising: monosaccharides; oligosaccharides in a ratio ≧0.06 to total saccharides; disaccharides in a ratio to total saccharides ≧0.05; pentose in a ratio to total saccharides ≧0.05; at least one alpha-bonded di-glucose; and at least one beta-bonded di-glucose. Also disclosed are methods to make and / or use such mixtures.
Owner:VIRIDA
Starch-based biodegradable material composition
ActiveUS20090075346A1Overcomes drawbackSugar derivativesHydrolasesCopolyesterPoly(butylene succinate)
A starch-based biodegradable material composition includes: an enzyme-hydrolyzed starch; and a biodegradable polyester selected from at least one of an aliphatic polyester of polybutylene succinate and an aliphatic-aromatic copolyester. The enzyme-hydrolyzed starch is prepared by hydrolyzing a native starch using a starch-hydrolyzing enzyme. The starch-hydrolyzing enzyme has an activity unit ranging from 15000 to 40000.
Owner:GRACE BIOTECH CORP
Method of reducing unpleasant taste and/or unpleasant odor
InactiveUS20060134197A1Reduce pungent tasteWeak harsh tasteConfectioneryCosmeticsAdditive ingredientOdor
The present invention has objects to provide a method of lowering the unpleasant taste and / or smell of compositions, and an agent for lowering unpleasant taste and / or smell. The objects are solved by providing a method of lowering unpleasant taste and / or smell, comprising a step of incorporating an saccharide derivative of α,α-trehalose in compositions; a composition with lowered unpleasant taste and / or smell, obtainable by the method; and an agent for lowering unpleasant taste and / or smell, comprising an saccharide derivatives of α,α-trehalose as an effective ingredients.
Owner:HAYASHIBARA BIOCHEMICAL LAB INC
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com